Combinations comprising anti-epileptic drugs for the treatment of neurological disorders

Details for Australian Patent Application No. 2004226825 (hide)

Owner Novartis AG

Inventors Schmutz, Markus; Aitken, David; Lingenhohl, Kurt

Agent Davies Collison Cave

Pub. Number AU-B-2004226825

PCT Pub. Number WO2004/087161

Priority 0307860.7 04.04.03 GB

Filing date 2 April 2004

Wipo publication date 14 October 2004

Acceptance publication date 16 August 2007

International Classifications

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087161 Priority application(s): WO2004/087161

16 August 2007 Application Accepted

  Published as AU-B-2004226825

13 December 2007 Standard Patent Sealed

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226827-Use of 10-hydroxy-10,11-dihydrocarbamazepin e derivatives for the treatment of affective disorders

2004226824-Quinoline-2-one-derivatives for the treatment of airways diseases